These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35764181)

  • 1. Prevalence and characteristics of multidrug-resistant Escherichia coli sequence type ST131 at two academic centers in Boston and Minneapolis, USA.
    Mahoney MT; Brigman HV; Johnston BD; Johnson JR; Hirsch EB
    Am J Infect Control; 2023 Apr; 51(4):434-439. PubMed ID: 35764181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.
    Tóth K; Tóth Á; Kamotsay K; Németh V; Szabó D
    Ann Clin Microbiol Antimicrob; 2022 Feb; 21(1):3. PubMed ID: 35144632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.
    Merino I; Hernández-García M; Turrientes MC; Pérez-Viso B; López-Fresneña N; Diaz-Agero C; Maechler F; Fankhauser-Rodriguez C; Kola A; Schrenzel J; Harbarth S; Bonten M; Gastmeier P; Canton R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2018 Nov; 73(11):2973-2980. PubMed ID: 30124851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
    Drawz SM; Porter S; Kuskowski MA; Johnston B; Clabots C; Kline S; Ferrieri P; Johnson JR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5331-9. PubMed ID: 26100703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of ST131 Subclades C2-
    Flament-Simon SC; García V; Duprilot M; Mayer N; Alonso MP; García-Meniño I; Blanco JE; Blanco M; Nicolas-Chanoine MH; Blanco J
    Front Cell Infect Microbiol; 2020; 10():125. PubMed ID: 32266173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla
    Johnston BD; Thuras P; Porter SB; Clabots C; Johnson JR
    Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2069-2075. PubMed ID: 33893571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
    Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
    [No Abstract]   [Full Text] [Related]  

  • 8. Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.
    Colpan A; Johnston B; Porter S; Clabots C; Anway R; Thao L; Kuskowski MA; Tchesnokova V; Sokurenko EV; Johnson JR;
    Clin Infect Dis; 2013 Nov; 57(9):1256-65. PubMed ID: 23926176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of ESBL-Producing
    Zendri F; Maciuca IE; Moon S; Jones PH; Wattret A; Jenkins R; Baxter A; Timofte D
    Microb Drug Resist; 2020 Jun; 26(6):697-708. PubMed ID: 32519936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 12. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
    Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
    Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftazidime-avibactam against Escherichia coli isolates from U.S. veterans (2011) in relation to co-resistance and sequence type 131 (ST131) H30 and H30Rx status.
    Johnston BD; Thuras PD; Johnson JR
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115034. PubMed ID: 32331800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.
    Matsumura Y; Pitout JDD; Peirano G; DeVinney R; Noguchi T; Yamamoto M; Gomi R; Matsuda T; Nakano S; Nagao M; Tanaka M; Ichiyama S
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584160
    [No Abstract]   [Full Text] [Related]  

  • 17.
    Johnson JR; Johnston B; Thuras P; Launer B; Sokurenko EV; Miller LG
    mSphere; 2016; 1(6):. PubMed ID: 27904884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
    Birgy A; Levy C; Nicolas-Chanoine MH; Cointe A; Hobson CA; Magnan M; Bechet S; Bidet P; Cohen R; Bonacorsi S
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive Genetic Commonality among Wildlife, Wastewater, Community, and Nosocomial Isolates of Escherichia coli Sequence Type 131 (
    Jamborova I; Johnston BD; Papousek I; Kachlikova K; Micenkova L; Clabots C; Skalova A; Chudejova K; Dolejska M; Literak I; Johnson JR
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061277
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.